MeiraGTx Holdings PLC
MGTX
Company Profile
Business description
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Contact
450 East 29th Street
14th Floor
New YorkNY10016
USAT: +1 646 860-7985
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
372
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,833.60 | 4.90 | 0.06% |
| CAC 40 | 7,754.55 | 16.13 | 0.21% |
| DAX 40 | 23,934.13 | 144.02 | 0.61% |
| Dow JONES (US) | 44,817.56 | 333.14 | 0.75% |
| FTSE 100 | 8,823.20 | 48.51 | 0.55% |
| HKSE | 24,069.94 | 151.47 | -0.63% |
| NASDAQ | 20,587.79 | 194.66 | 0.95% |
| Nikkei 225 | 39,785.90 | 23.42 | 0.06% |
| NZX 50 Index | 12,704.48 | 79.81 | -0.62% |
| S&P 500 | 6,275.88 | 48.46 | 0.78% |
| S&P/ASX 200 | 8,595.80 | 1.90 | -0.02% |
| SSE Composite Index | 3,461.15 | 6.36 | 0.18% |